(Oct. 9, 2020) – A novel psychoactive substance, flualprazolam, has been identified in recent deaths that occurred in Kansas. NPS benzodiazepines, sometimes referred to as designer benzodiazepines, are synthetically manufactured drugs, often associated with unknown biological effects and health risks, a dangerous combination for any recreational drug user. NPS benzodiazepines resemble traditional benzodiazepines, such as diazepam and alprazolam, but differ with the addition of new elements or functional groups. NPS benzodiazepines are often prepared in powder or tablet form and can be mixed with street-level drugs, including traditional benzodiazepines and opioids.
Flualprazolam was first identified in the United States in March 2018; however, the popularity of flualprazolam has increased. Postmortem toxicology testing has revealed flualprazolam, combined with fentanyl, in recent deaths in Kansas.
More details are available online.